Holen Sie sich die Stockscreener-App
16.81
0.88%
-0.15
Vorhandelsmarkt:
17.20
0.39
+2.32%
Schlusskurs vom Vortag:
$16.96
Offen:
$16.8
24-Stunden-Volumen:
172.00K
Relative Volume:
0.35
Marktkapitalisierung:
$5.95B
Einnahmen:
$4.89B
Nettoeinkommen (Verlust:
$-263.00M
KGV:
-21.74
EPS:
-0.7734
Netto-Cashflow:
$-167.84M
1W Leistung:
+3.77%
1M Leistung:
+12.07%
6M Leistung:
+46.05%
1J Leistung:
-14.84%
1-Tages-Spanne:
$16.80
$17.15
1-Wochen-Bereich:
$16.03
$17.70
52-Wochen-Spanne:
$10.45
$20.71
Bausch Lomb Corp Stock (BLCO) Company Profile
Firmenname
Bausch Lomb Corp
Sektor
Telefon
908-541-5456
Adresse
520 APPLEWOOD CRESCENT, VAUGHAN
Vergleichen Sie BLCO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
16.81 | 6.01B | 4.89B | -263.00M | -167.84M | -0.7734 |
|
ISRG
Intuitive Surgical Inc
|
568.65 | 201.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.76 | 55.25B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.99 | 39.31B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
251.51 | 36.70B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
281.77 | 20.45B | 2.96B | 487.70M | 344.00M | 6.6758 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-10-01 | Eingeleitet | Goldman | Neutral |
| 2025-05-02 | Bestätigt | H.C. Wainwright | Buy |
| 2025-03-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-07-10 | Eingeleitet | Raymond James | Outperform |
| 2024-05-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-12-12 | Eingeleitet | Stifel | Hold |
| 2023-10-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-09 | Eingeleitet | Needham | Hold |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-06-24 | Eingeleitet | Evercore ISI | Outperform |
| 2022-06-06 | Eingeleitet | Citigroup | Buy |
| 2022-05-31 | Eingeleitet | Deutsche Bank | Hold |
| 2022-05-31 | Eingeleitet | Goldman | Neutral |
| 2022-05-31 | Eingeleitet | Guggenheim | Buy |
| 2022-05-31 | Eingeleitet | JP Morgan | Neutral |
| 2022-05-31 | Eingeleitet | Jefferies | Buy |
| 2022-05-31 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-05-11 | Eingeleitet | Cowen | Outperform |
Alle ansehen
Bausch Lomb Corp Aktie (BLCO) Neueste Nachrichten
Is Bausch + Lomb Corporation (S2L) stock a defensive play amid uncertainty2025 EndofYear Setup & Trade Opportunity Analysis Reports - Newser
Is Bausch + Lomb Corporation (S2L) stock a fit for income portfoliosJuly 2025 Rallies & Low Drawdown Momentum Ideas - Newser
Wall Street Cautious on Bausch + Lomb Corporation (BLCO), Here's Why - Finviz
Wall Street Cautious on Bausch + Lomb Corporation (BLCO), Here’s Why - Insider Monkey
Will Bausch + Lomb Corporation stock gain from lower inflationJuly 2025 Summary & Stock Timing and Entry Methods - Newser
Needham Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating - 富途牛牛
Balanced Hold Rating on Bausch + Lomb Amid Strategic Updates and Long-term Uncertainties - TipRanks
Is Bausch + Lomb Corporation (S2L) stock suitable for passive index fundsPortfolio Performance Report & Accurate Buy Signal Alerts - Newser
Morgan Stanley Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛
BLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point? - AOL.com
Bausch + Lomb (NYSE:BLCO) Shares Gap UpTime to Buy? - MarketBeat
BLCO Stock Still 16% Below IPO — Is Silver Point’s $38.7 Million Bet a Turning Point? - The Motley Fool
River Road Asset Management LLC Lowers Stock Position in Bausch + Lomb Corporation $BLCO - MarketBeat
Bausch + Lomb and Ripple Therapeutics partner to develop sustained-release implants - Eyes On Eyecare
Will Bausch + Lomb Corporation (S2L) stock see valuation expansion2025 Historical Comparison & AI Based Buy and Sell Signals - Newser
9 Best Up and Coming Canadian Stocks to Buy - Insider Monkey
(BLCO) Strategic Equity Report (BLCO:CA) - news.stocktradersdaily.com
Bausch + Lomb Shares Rise After Morgan Stanley Upgrade - marketscreener.com
Why Bausch + Lomb (BLCO) Stock Is Up Today - Finviz
Bausch + Lomb upgraded at Morgan Stanley on pipeline - Seeking Alpha
Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equal Weight, Adjusts PT to CA$29.41 From CA$19.64 - marketscreener.com
What analyst consensus says on Bausch + Lomb Corporation stock2025 Historical Comparison & Reliable Price Breakout Signals - Newser
Can Bausch + Lomb Corporation (S2L) stock double in coming yearsTrade Analysis Report & Free Expert Approved Momentum Trade Ideas - Newser
Published on: 2025-12-02 01:18:08 - Newser
Bausch + Lomb (BLCO): Is the Current Valuation Overlooked After Recent Share Recovery? - Yahoo Finance
Handelsbanken Fonder AB Takes Position in Bausch + Lomb Corporation $BLCO - MarketBeat
(BLCO) Equity Trading Insights (BLCO:CA) - news.stocktradersdaily.com
BofA rates Bausch & Lomb ‘underperform’ with lower buyout chances - MSN
Behavioral Patterns of BLCO and Institutional Flows - news.stocktradersdaily.com
(BLCO) Market Performance Analysis (BLCO:CA) - news.stocktradersdaily.com
Bausch + Lomb Lifts Guidance After Beating Earnings Forecasts - Finimize
Long Term Trading Analysis for (BLCO) (BLCO:CA) - news.stocktradersdaily.com
Citigroup Downgrades Bausch + Lomb (BLCO) - MSN
How Bausch + Lomb Corporation (S2L) stock responds to bond market2025 Market Outlook & Weekly Top Gainers Alerts - newser.com
Is Bausch + Lomb Corporation stock a buy for dividend growthJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Is Bausch + Lomb Corporation (S2L) stock worth buying before Fed actionMarket Movement Recap & Consistent Profit Trading Strategies - newser.com
How big funds are accumulating Bausch + Lomb Corporation (S2L) stockJuly 2025 Intraday Action & AI Enhanced Execution Alerts - newser.com
Trading (BLCO) With Integrated Risk Controls (BLCO:CA) - news.stocktradersdaily.com
Will Bausch + Lomb Corporation stock benefit from commodity supercycleJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Will Bausch + Lomb Corporation stock announce special dividend2025 Fundamental Recap & AI Based Buy and Sell Signals - newser.com
Why global investors buy Bausch + Lomb Corporation stockEntry Point & Weekly Breakout Opportunity Watchlist - newser.com
Does Bausch + Lomb Corporation (S2L) stock trade below intrinsic valueWeekly Market Summary & Expert Approved Momentum Ideas - newser.com
Bausch + Lomb to Engage at Citi Global Healthcare Conference - The Globe and Mail
Real time breakdown of Bausch + Lomb Corporation stock performancePortfolio Risk Report & Weekly Consistent Profit Watchlists - newser.com
Finanzdaten der Bausch Lomb Corp-Aktie (BLCO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.17%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):